Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research from Malmo University provides new data on breast cancer
May 14th, 2009
According to a study from Malmo, Sweden, "One third of all breast cancers are estrogen receptor alpha (ER alpha) negative, carry a poor overall prognosis, and do not respond well to currently available endocrine therapies. New treatment strategies are therefore required." "Loss of Wnt-5a has previously been correlated with loss of ER alpha in clinical breast cancer samples, and we sought to investigate this association further. Three breast cancer cell lines (MDA-MB-231, MDA-MB-468, and 4T1) lacking expression of ER alpha and Wnt-5a, and one breast cancer cell line (T47D) expressing both proteins were used in this study. Wnt-5a signaling was generated in ER...
Source: Women's Health Weekly (2009-05-14)
|
